DYAX Aktie

1,37 EUR 2,4682%

Zu Ihrem Onlinebroker

kaufen verkaufen

DYAX Aktienkurs : 25.05. ( 15 Min. verzögert)
1,37 € Letzter Kurs	2,47% Veränderung	1,34 € Vortag	1,36 € Eröffnungskurs

mehr Informationen

Hoch/Tief		Volumen		Geldkurs	Briefkurs
1,37 - 1,36 Tag	1,61 - 0,837 52 Wochen	0 Tag	10 Ø 52 Wochen	0,0000000 0 Stücke	0,0000000 0 Stücke

DYAX Aktienkurs

Wollen Sie wissen, wie es mit dieser Aktie weitergeht?
Wir informieren Sie kostenlos.

Erhalten Sie außerdem Expertenanalysen von:
Gevestor Täglich und John Gossens Daily DAX

25.05.

Dyax Launches HAE Diagnostic Testing Refund Program to Encourage Proper ...

(NASDAQ: DYAX) the manufacturer of KALBITOR® (ecallantide) for the treatment of acute attacks of hereditary angioedema (HAE) in patients 16 years of...
24.05.

Dyax Launches HAE Diagnostic Testing Refund Program to Encourage Proper ...

(NASDAQ:DYAX) the manufacturer of KALBITOR(R) (ecallantide) for the treatment of acute attacks of hereditary angioedema (HAE) in patients 16 years of age and older, has announced the launch of its HA…

16.05.

Dyax Corp. Reaffirms Commitment to Supporting Patients with Hereditary ...

As awareness activities take place today across the globe in recognition of Hereditary Angioedema (HAE) Day –– Dyax Corp. (NASDAQ: DYAX) has announced a donation of $25000 to the United States Hereditary Angioedema Association (HAEA) – the largest...
16.05.

Dyax Corp. Reaffirms Commitment to Supporting Patients with Hereditary ...

(NASDAQ:DYAX) has announced a donation of $25000 to the United States Hereditary Angioedema Association (HAEA) -- the largest HAE patient group in the world. This donation is one of several activitie…
11.05.

Dyax Corp. Launches Hereditary Angioedema (HAE) Attack Tracker(TM), a Free ...

(NASDAQ:DYAX) today announced the launch of a free smartphone application for the iPhone -- HAE Attack Tracker(TM). This application allows HAE patients to keep detailed records of their disease rela…